Lung Cancer Clinical Trials

Showing 1741-1760 of 2,032 trials

A Study to Diagnose Lung Cancer by Sputum Cytology (01-312)

NCT00210080

The primary objective of this study is to determine if more diagnoses of lung cancer are obtained from the cytological evaluation of sputum expectorated following a single inhaled dose of UTP compared to sputum expectorated following a single inhaled dose of placebo in patients suspected of having lung cancer.

Lung Cancer

Merck Sharp & Dohme LLC700 participantsStarted Apr 2001

UNKNOWNPhase 1

A Open-label Prospective Cohort Trial of Curcumin Plus Tyrosine Kinase Inhibitors (TKI) for EGFR -Mutant Advanced NSCLC

NCT02321293

The purpose of this study is is to assess the safety and tolerability of curcumin in combination with EGFR-TKIs in selected patients with advanced non-resectable mutant EGFR NSCLC.

Lung Cancer

Lady Davis Institute20 participantsStarted Aug 2015

Montreal, Quebec, Canada

TERMINATEDNA

Effectiveness of Additional Acupuncture Therapy for Lung Cancer Patients

NCT01408212

This study aims for evaluating the effectiveness, safety and feasibility of additional acupuncture therapy for lung cancer patients who are under chemotherapy in an inpatient setting. The acupuncture therapy will be administered during a resting period between cycles of chemotherapy.

Lung Cancer

Korean Medicine Hospital of Pusan National University11 participantsStarted Jul 2011

Yangsan, Gyeongsangnam-do, South Korea

A Study to Diagnose Lung Cancer by Sputum Cytology (01-312)

A Open-label Prospective Cohort Trial of Curcumin Plus Tyrosine Kinase Inhibitors (TKI) for EGFR -Mutant Advanced NSCLC

Effectiveness of Additional Acupuncture Therapy for Lung Cancer Patients

Related Searches

Dose-Finding Study of Cabozantinib (XL184) in Japanese Subjects With Advanced Cancer

Tumor Associated Macrophage in Advanced Non-small Cell Lung Cancer

Influence of Prior Chemotherapy on Clinical Benefit With Erlotinib in Patients With Advanced Non-Squamous Non-Small Cell Lung Cancer With or Without EGFR Gene Mutation

A Study of Alimta/Cisplatin/Gefitinib for Asian Non-smoking Participants With Non Small Cell Lung Cancer

Prognostic Value of Divpenia and CD4 Count in Relapsed Breast or Lung Cancer Patients

Coagulation Profile in Patients Undergoing Video Assisted Thorascopic Surgery (VATS) for Lung Cancer

Airway Epithelium Gene Expression: AEGIS IDE

Icotinib as Adjuvant Therapy in Treating Non-small-cell Lung Cancer Patients With Positive EGFR Mutation

Epidemiological Study to Describe Non Small Cell Lung Cancer (NSCLC) Clinical Management Patterns in Central Eastern Europe and Russia (Lung-EPICLIN)

EF5 in Assessing Tumor Response to Anticancer Therapy in Patients With Stage I, Stage II, or Stage III Non-Small Cell Lung Cancer

Immunotoxin Therapy in Treating Patients With Advanced Cancer

Paclitaxel and Hyperthermic Perfusion in Treating Patients With Lung Cancer or Lung Metastases That Cannot Be Removed By Surgery

Fluorescent Light Bronchoscopy Plus White Light Bronchoscopy for Early Detection of Lung Cancer

Sequential Icotinib Plus Chemotherapy Versus Icotinib Alone as First-line Treatment in Stage IIIB/IV Lung Adenocarcinoma

Does Moderate Intensity Exercise Help Prevent Smoking Relapse Among Women?

Prophylactic Cranial Irradiation (PCI) vs Observation in Stage III NSCLC

A Clinical Study on the Safety and Efficacy of Debio 0932 in Combination With Standard of Care in Patients With Non-small Cell Lung Cancer [NSCLC]